Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05275608 Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT05275608
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 25 and 65 years old
  • People with a body mass index (BMI) between 30 and 40 (a measure of body weight relative to height that falls in the obesity range)
  • People who have been diagnosed with a liver condition called NAFLD (non-alcoholic fatty liver disease, where excess fat builds up in the liver)
  • People who have type 2 diabetes that is being managed with medication (such as metformin or certain other diabetes drugs) and whose blood sugar control falls within a specific range — not well enough controlled but not extremely high (confirm with trial site)

Who may not be able to join:

  • People whose obesity is caused by a genetic condition or a hormonal/glandular disorder
  • People with kidney disease where kidney function is significantly reduced, or who have high levels of protein in their urine, or kidney stones
  • People whose diabetes requires both long-acting and short-acting insulin injections, or whose blood sugar levels are very poorly controlled (above a certain threshold)
  • People who have a type of diabetes other than type 2 diabetes
  • People with conditions affecting the pituitary gland or adrenal glands that reduce their normal hormone output
  • People who have taken antibiotics in the three months before their first visit to the trial site

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 0321 660 693

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita
Registry
ClinicalTrials.gov
Start date
7 November 2022
Est. completion
1 September 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in weight; Change in body circumferences; Change in metabolic control; Change in metabolic control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov